Trade-Ideas LLC identified Akorn Inc. (NASDAQ:AKRX) as a new lifetime high candidate. TheStreet Quant Ratings rates the company as a buy. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. Akorn, Inc. (NASDAQ:AKRX) net profit margin is 15.30% and weekly performance is 5.67%. On last trading day company shares ended up $28.33. Analysts mean target price for the company is $29.75. Akorn, Inc. (NASDAQ:AKRX) distance from 50-day simple moving average (SMA50) is 18.88%.
pSivida Corp. (NASDAQ:PSDV) 8% HIGHER on 14 May 2014; reported Q3 EPS of ($0.08), $0.07 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $2 million versus the consensus estimate of $550 thousand. pSivida Corp. (NASDAQ:PSDV) shares fell -1.61% in last trading session and ended the day on $3.66. PSDV return on assets is -62.10%. pSivida Corp. (NASDAQ:PSDV) quarterly performance is -18.30%.
Drugmakers Eli Lilly and Co (NYSE:LLY) and Boehringer Ingelheim said Friday European Union regulators approved their type 2 diabetes drug Jardiance. Eli Lilly and Co (NYSE:LLY) shares moved up 0.13% in last trading session and was closed at $59.80, while trading in range of $59.40 – $59.86. Eli Lilly and Co (NYSE:LLY) year to date (YTD) performance is -7.81%.
News reports have speculated that Allergan is talking to Sanofi S.A. (ADR) (NYSE:SNY) and Johnson & Johnson (J&J) for rival bids, and that it is looking to acquire Shire PLC to fend off the Valeant bid. Allergan’s shares are up 13% since the bid was announced. Sanofi SA (ADR) (NYSE:SNY) ended the last trading day at $52.79. Company weekly volatility is calculated as 085% and price to cash ratio as 24.41. Sanofi SA (ADR) (NYSE:SNY) showed a negative weekly performance of -0.58%.
On 2 May 2014, Merck KGaA (ADR) (OTCMKTS:MKGAY), Darmstadt, Germany (Merck ) announced that all of the Conditions to its recommended cash offer (the Offer ) made by Merck 15. Allgemeine Beteiligungs-GmbH (Bidco ) for the entire issued and to be issued share capital of AZ Electronic Materials S.A. (AZ ) had been satisfied or waived and the Offer was declared unconditional in all respects. Further, on 8 May 2013, Merck announced that the Offer would close at 1.00 p.m. (London time) / 2.00 p.m. (CET) on 23 May 2014. Merck KGaA (ADR) (OTCMKTS:MKGAY) on last trading day company shares ended up $57.13.